Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doms

Showing results (271-280 of 335) with videos related to

Pageof 34
Sort By:
Nature|January 24, 1998
A new classification for HIV-1E A Berger, R W Doms, E M Fenyö, et al.
Journal of Virology|August 8, 1998
Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4B Lee, B J Doranz, S Rana, et al.
AIDS Research and Human Retroviruses|January 9, 2010
HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entryJohn C Tilton, Heather Amrine-Madsen, John L Miamidian, et al.
The Journal of General Virology|November 22, 2005
Presence of broadly reactive and group-specific neutralizing epitopes on newly described isolates of Crimean-Congo hemorrhagic fever virusAsim A Ahmed, Jeanne M McFalls, Christian Hoffmann, et al.
The Journal of Biological Chemistry|November 27, 1999
Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env proteinC Blanpain, B J Doranz, J Vakili, et al.
Cell Host & Microbe|May 21, 2013
Quantitative phosphoproteomics reveals extensive cellular reprogramming during HIV-1 entryJason A Wojcechowskyj, Chuka A Didigu, Jessica Y Lee, et al.
Journal of Virology|November 26, 1997
Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency virusesJ Rucker, A L Edinger, M Sharron, et al.
Nature Immunology|February 27, 2004
HIV vaccine design and the neutralizing antibody problemDennis R Burton, Ronald C Desrosiers, Robert W Doms, et al.
Diabetes|April 23, 2008
Protein engineering strategies for sustained glucagon-like peptide-1 receptor-dependent control of glucose homeostasisKristen M Picha, Mark R Cunningham, Daniel J Drucker, et al.
Cell|November 1, 1996
Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificityJ Rucker, M Samson, B J Doranz, et al.
Pageof 34

Showing results (271-280 of 335) with videos related to

Sort By:
Pageof 34
Nature|January 24, 1998
A new classification for HIV-1E A Berger, R W Doms, E M Fenyö, et al.
Journal of Virology|August 8, 1998
Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4B Lee, B J Doranz, S Rana, et al.
AIDS Research and Human Retroviruses|January 9, 2010
HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entryJohn C Tilton, Heather Amrine-Madsen, John L Miamidian, et al.
The Journal of General Virology|November 22, 2005
Presence of broadly reactive and group-specific neutralizing epitopes on newly described isolates of Crimean-Congo hemorrhagic fever virusAsim A Ahmed, Jeanne M McFalls, Christian Hoffmann, et al.
The Journal of Biological Chemistry|November 27, 1999
Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env proteinC Blanpain, B J Doranz, J Vakili, et al.
Cell Host & Microbe|May 21, 2013
Quantitative phosphoproteomics reveals extensive cellular reprogramming during HIV-1 entryJason A Wojcechowskyj, Chuka A Didigu, Jessica Y Lee, et al.
Journal of Virology|November 26, 1997
Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency virusesJ Rucker, A L Edinger, M Sharron, et al.
Nature Immunology|February 27, 2004
HIV vaccine design and the neutralizing antibody problemDennis R Burton, Ronald C Desrosiers, Robert W Doms, et al.
Diabetes|April 23, 2008
Protein engineering strategies for sustained glucagon-like peptide-1 receptor-dependent control of glucose homeostasisKristen M Picha, Mark R Cunningham, Daniel J Drucker, et al.
Cell|November 1, 1996
Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificityJ Rucker, M Samson, B J Doranz, et al.
Pageof 34